KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.

Yan Zhao, Litao Zhang, Jianzhong Zhang, CM310AD005 Study Investigators

J Am Acad Dermatol 91(5) 984-986

PMID39038559
PMCID-
DOI10.1016/j.jaad.2024.07.1447
发表日期2024-07-22
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。